Systemic sclerosis: Recent insight in clinical management

This publication has 70 references indexed in Scilit:

• Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial
  The Lancet, 2016
• Efficacy of sildenafil on ischaemic digital ulcer healing in systemic sclerosis: the placebo-controlled SEDUCE study
  Annals of the Rheumatic Diseases, 2016
• Digital ulcers predict a worse disease course in patients with systemic sclerosis
  Annals of the Rheumatic Diseases, 2016
• Derivation and External Validation of a Prediction Rule for Five‐Year Mortality in Patients With Early Diffuse Cutaneous Systemic Sclerosis
  Arthritis & Rheumatology, 2016
• Performance of the new ACR/EULAR classification criteria for systemic sclerosis in clinical practice
  Rheumatology, 2015
• Lung and heart-lung transplantation for systemic sclerosis patients. A monocentric experience of 13 patients, review of the literature and position paper of a multidisciplinary Working Group
  La Presse Médicale, 2014
• Borderline Mean Pulmonary Artery Pressure in Patients With Systemic Sclerosis: Transpulmonary Gradient Predicts Risk of Developing Pulmonary Hypertension
  Arthritis & Rheumatism, 2012
• Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial
  The Lancet, 2011
• Interstitial Lung Disease in Systemic Sclerosis
  American Journal of Respiratory and Critical Care Medicine, 2008
• Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database
  Annals of the Rheumatic Diseases, 2007